- Trials with a EudraCT protocol (79)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (42)
79 result(s) found for: cerebral palsy.
Displaying page 3 of 4.
EudraCT Number: 2016-000222-19 | Sponsor Protocol Number: H2020-PHC-18-2015-667224 | Start Date*: 2017-08-02 | ||||||||||||||||
Sponsor Name:University Hospital Tuebingen | ||||||||||||||||||
Full Title: Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiori... | ||||||||||||||||||
Medical condition: Perinatal Asphyxia, hypoxic-ischemic brain injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Trial now transitioned) NL (Trial now transitioned) NO (Trial now transitioned) ES (Ongoing) FI (Trial now transitioned) EE (Trial now transitioned) AT (Trial now transitioned) BE (Trial now transitioned) PT (Prematurely Ended) IT (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000422-38 | Sponsor Protocol Number: PET_imaging_of_Tau | Start Date*: 2014-09-19 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Skåne University Hospital, Region Skåne | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: An open-label study evaluating the diagnostic accuracy of [18F]-AV-1451 PET to detect and distinguish neurodegenerative disorders characterized by cerebral accumulation of tau | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Neurodegenerative disorders with Tau-pathology; including Alzheimer's disease, progressive supranuclear palsy, frontotemporal dementia, corticobasal degeneration and important differential diagnost... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002175-40 | Sponsor Protocol Number: no number | Start Date*: 2008-12-17 |
Sponsor Name: | ||
Full Title: Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills | ||
Medical condition: Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the ... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005678-36 | Sponsor Protocol Number: 06-APR-02 | Start Date*: 2008-07-03 |
Sponsor Name:CHU de Nice | ||
Full Title: Oral alendronate for osteoporosis treatment in non-walking children with cerebral palsy | ||
Medical condition: osteoporosis treatment in non-walking children with cerebral palsy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-001300-30 | Sponsor Protocol Number: 2017_CERVPLEX_1.1 | Start Date*: 2017-10-03 |
Sponsor Name:UK für Anästhesieologie, Gemeinn. Sbg. Landeskliniken BetriebsgesmbH | ||
Full Title: Comparison of deep, intermediate and superficial cervical plexus block for carotid endarterectomies concerning paresis of the phrenic nerve, lung function and tissue distribution: a prospective, ra... | ||
Medical condition: deep, intermediate or superficial cervical plexus block for carotid endarterectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004685-17 | Sponsor Protocol Number: ERA2005neuro | Start Date*: 2005-11-16 |
Sponsor Name:CUB - Hôpital Erasme | ||
Full Title: A prospective placebo controlled study of botulilium toxin (BOTOX) on gait disorder induced by spastic equinovarus foot. | ||
Medical condition: Spastic equinus foot is a common dynamic deformity in patients with cerebral palsy. This dynamic deformity, mainly caused by spasticity of the soleus, gastrocnemius and tibialis posterior muscles, ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003242-34 | Sponsor Protocol Number: 67103 | Start Date*: 2005-11-21 | |||||||||||
Sponsor Name:National Institutes of Neurological Disorders: Stroke | |||||||||||||
Full Title: Secondary Prevention of Small Subcortical Strokes | |||||||||||||
Medical condition: Secondary prevention of small subcortical strokes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000352-36 | Sponsor Protocol Number: HP-ALS-TIA | Start Date*: 2020-04-27 | |||||||||||
Sponsor Name:Christoffer Laustsen | |||||||||||||
Full Title: MRI of neurometabolic impairment in ALS and TIA using hyperpolarized pyruvate | |||||||||||||
Medical condition: Amyotrophic lateral sclerosis Transient ischemic attack | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004370-55 | Sponsor Protocol Number: 2007-004370-55 | Start Date*: 2007-12-14 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Effects of tetrahydrobiopterin (6R-BH4) on flow-mediated dilation in CADASIL patients: a randomised controlled trial | |||||||||||||
Medical condition: CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), is a rare autosomal dominant disorder characterized by recurrent strokes starting in mid-adulth... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004057-23 | Sponsor Protocol Number: 2021-12945 | Start Date*: 2022-02-28 |
Sponsor Name:Radboudumc | ||
Full Title: Ethanol submandibular duct ligation for drooling in children with neurodisabilities | ||
Medical condition: Drooling or sialorrhea | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002095-17 | Sponsor Protocol Number: MAGSPET | Start Date*: 2011-09-13 | |||||||||||
Sponsor Name:Anna Suy Franch | |||||||||||||
Full Title: Sulfato de magnesio en pauta continua versus discontinua en la conducta expectante de la preeclampsia grave: ensayo clínico aleatorizado | |||||||||||||
Medical condition: Preeclampsia grave | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000094-36 | Sponsor Protocol Number: BioFINDER_2 | Start Date*: 2017-03-31 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Skåne University Hospital | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Neurodegenerative disorders with Tau-pathology; including, but not limited to, Alzheimer's disease, progressive supranuclear palsy, frontotemporal dementia, corticobasal degeneration and mild cogni... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000062-38 | Sponsor Protocol Number: 191622-101 | Start Date*: 2013-07-08 | ||||||||||||||||
Sponsor Name:Allergan Limited | ||||||||||||||||||
Full Title: BOTOX® Treatment in Pediatric Upper Limb Spasticity: Double-blind Study | ||||||||||||||||||
Medical condition: Upper Limb Spasticity. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) PL (Completed) HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000042-35 | Sponsor Protocol Number: 191622-111 | Start Date*: 2013-07-08 | ||||||||||||||||
Sponsor Name:Allergan Limited | ||||||||||||||||||
Full Title: BOTOX® Treatment in Pediatric Lower Limb Spasticity: Double-blind Study | ||||||||||||||||||
Medical condition: Lower Limb Spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) PL (Completed) HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-005915-13 | Sponsor Protocol Number: TRx-014-002 | Start Date*: 2006-07-12 | |||||||||||
Sponsor Name:TauRx Therapeutics PTE Ltd | |||||||||||||
Full Title: An Open Pilot Study of Methlythioninium Chloride (MTC) in Frontotemporal Dementia and Related Dementia Syndromes | |||||||||||||
Medical condition: Frontotemporal Dementia and related syndromes Prevention and reversal of tau protein aggregation is a novel approach to the treatment of patients with FTD and related syndromes and has the potent... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-006174-97 | Sponsor Protocol Number: BST22006 | Start Date*: 2007-05-02 |
Sponsor Name:University of Oxford, Research Governance & Clinical Trials Office | ||
Full Title: Which oxygen saturation level should we use for very premature infants? A randomised controlled trial (BOOST-II UK) | ||
Medical condition: Respiratory distress of newborn ICD codes P22.0, P22.8, P22.9 | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-004314-16 | Sponsor Protocol Number: 1 R01 NS45109-01A1 | Start Date*: 2005-04-25 |
Sponsor Name:NINDS | ||
Full Title: Ensayo multicéntrico de tratamiento de la hipotiroxinemia transitoria en los niños <= 1000 gr de peso al nacimiento o <= 28 semanas de gestación y seguimiento del desarrollo psicomotor hasta los 5 ... | ||
Medical condition: The aims of the study are to compare two dosing levels and the mode of administration of thyroid hormones or iodine supplementation in premature infants to achieve optimal plasma hormone targets. T... | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000043-27 | Sponsor Protocol Number: 191622-105 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:Allergan Limited | ||||||||||||||||||
Full Title: BOTOX® Treatment in Pediatric Upper Limb Spasticity: Open-label Study | ||||||||||||||||||
Medical condition: Upper limb spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) PL (Completed) HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000084-24 | Sponsor Protocol Number: 191622-112 | Start Date*: 2013-07-08 | ||||||||||||||||
Sponsor Name:Allergan Limited | ||||||||||||||||||
Full Title: BOTOX® Treatment of Pediatric Lower Limb Spasticity: Open-label Study | ||||||||||||||||||
Medical condition: Lower Limb Spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) PL (Completed) HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003225-41 | Sponsor Protocol Number: 233AS102 | Start Date*: 2017-04-10 | ||||||||||||||||
Sponsor Name:Biogen Idec Research Limited | ||||||||||||||||||
Full Title: An Extension Study to Assess the Long-Term Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB067 Administered to Previously Treated Adults with Amyotrophic Lateral Sc... | ||||||||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis (ALS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) GB (GB - no longer in EU/EEA) DE (Ongoing) DK (Completed) PL (Completed) ES (Prematurely Ended) IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
